Skip to main content

Peer Review reports

From: Efficacy and safety of levothyroxine monotherapy in lowering the risk of cardiovascular disease in older adults with subclinical hypothyroidism: research protocols of a multicenter, open-label, randomized controlled trial

Original Submission
14 Feb 2025 Submitted Original manuscript
2 Mar 2025 Author responded Author comments - Chong - Xu
Resubmission - Version 2
2 Mar 2025 Submitted Manuscript version 2
11 Mar 2025 Author responded Author comments - Chong - Xu
Resubmission - Version 3
11 Mar 2025 Submitted Manuscript version 3
20 Mar 2025 Reviewed Reviewer Report - Masahide Hamaguchi
22 Mar 2025 Reviewed Reviewer Report - Mohadeseh Badpeyma
22 Mar 2025 Reviewed Reviewer Report - Carolina Amaral-Moreira
23 Mar 2025 Reviewed Reviewer Report - Ibrahem Abdalaziz Ibrahem Abdalhakam
29 Mar 2025 Reviewed Reviewer Report - Alisia Carnemolla
30 Mar 2025 Reviewed Reviewer Report - Shriya Das
18 Apr 2025 Author responded Author comments - Chong - Xu
Resubmission - Version 4
18 Apr 2025 Submitted Manuscript version 4
19 Apr 2025 Reviewed Reviewer Report - Carolina Amaral-Moreira
20 Apr 2025 Reviewed Reviewer Report - Masahide Hamaguchi
21 Apr 2025 Reviewed Reviewer Report - Ibrahem Abdalaziz Ibrahem Abdalhakam
Resubmission - Version 5
Submitted Manuscript version 5
Publishing
28 Apr 2025 Editorially accepted
15 May 2025 Article published 10.1186/s13063-025-08857-z

You can find further information about peer review here.

Back to article page